Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Product Unit Size | Cost | Quantity | Stock |
---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Cas No. | 2170137-61-6 (free base) |
---|---|
Purity | ≥98% |
Formula | C16H25N5 |
Formula Wt. | 287.41 |
IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
Synonym | KB0742, NSC-834161, NSC834161 |
Appearance | Yellow to brown crystal |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Side chain attached to various taxanes.
SERM, androgen modulator.
Diterpene found in tobacco plants and cigarette...
Endogenous peptide hormone, involved in cell gr...
BRG1/BRM ATPase inhibitor
Vitamin B1
Viologen derivative
Active metabolite of losartan
β-adrenergic antagonist.
Calcium channel blocker.
PKA inhibitor, potential ROCK, S6K1, MSK1, PKB ...
Marine toxin; actin polymerization inducer.
Vitamin D2, ergocalciferol metabolite; VDR agon...
PKG inhibitor.
Furanolactone found in Citrus.
Triterpene saponin found in species of Panax.
Deubiquitinating enzyme inhibitor.
Camptothecin analog; topoisomerase I inhibitor,...
EGFR inhibitor.
D2/3 antagonist, hERG K+ channel blocker.